FIELD: biotechnology.
SUBSTANCE: SC suspension in sodium alginate solution is passed through a nozzle in a electrostatic field and the microcapsules are stabilized in a solution with osmolality of 0.23-0.31 osmol/kg, containing 40-60 mmol/l of calcium chloride and 40-60 mmol/l of barium chloride.
EFFECT: method provides optimal timing of obtained microcapsules biodegradation, namely 14 days, and encapsulated cells survival of more than 50 percent within this period.
3 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MODELING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION | 2018 |
|
RU2675353C1 |
| METHOD FOR MICROENCAPSULATION OF SERTOLI CELLS, PRODUCED MICROCAPSULES AND USE THEREOF FOR PREVENTING AND TREATING SUGAR DIABETES TYPE 1 | 2009 |
|
RU2598736C2 |
| ENCAPSULATION SYSTEM FOR PROTECTION OF PROBIOTICS DURING PROCESSING | 2012 |
|
RU2577980C2 |
| METHOD FOR PREPARING MICROCAPSULES WITH LANGERHANS ISLETS AND MICROCAPSULE ACCORDING TO DISCLOSED METHOD | 2023 |
|
RU2822875C1 |
| METHOD OF PRODUCING ALGINATE-CHITOSAN MICROCAPSULES WITH VINPOCETINE | 2019 |
|
RU2716000C1 |
| METHOD OF PRODUCING MODIFIED ALGINATE MICROSPHERES | 2015 |
|
RU2606843C1 |
| METHOD FOR PRODUCING PARTICLES OF MICROCAPSULATED PHENHIBUT IN ALGINATE SODIUM | 2017 |
|
RU2662173C1 |
| DRUG FORM OF DISULFIRAM WITH PROLONGED ACTION AND METHOD OF ITS OBTAINING | 2011 |
|
RU2462235C1 |
| COMPOSITION OF ENCAPSULATED LIVER CELLS | 2010 |
|
RU2564924C2 |
| INCAPSULATED HEPATOCYTE COMPOSITION | 2010 |
|
RU2500390C2 |
